Bluejay Diagnostics Inc

BJDX11 Dec 2024
Healthcare
$4.26
-0.12 (-12.40%)
Lowest Today
$4.24
Highest Today
$4.34
Today’s Open
$4.26
Prev. Close
$4.84
52 Week High
$1372
52 Week Low
$3.03
To Invest in Bluejay Diagnostics Inc

Bluejay Diagnostics Inc

Healthcare
BJDX11 Dec 2024
-0.12 (-12.40%)
1M
3M
6M
1Y
5Y
Low
$4.24
Day’s Range
High
$4.34
4.24
52 Week Low
$3.03
52-Week Range
52 Week High
$1372
3.03
1 Day
-
1 Week
+30.16%
1 month return
+4974.15%
3 month return
+3097.59%
6 month return
+28.07%
1 Year return
-80.96%
3 Years return
-99.02%
5 Years return
-
10 Years return
-
Institutional Holdings
Anson Funds Management LP
1.16
Renaissance Technologies Corp
0.5
CVI Holdings LLC
0.24
UBS Group AG
0.22
TWO SIGMA SECURITIES, LLC
0.19
Citadel Advisors Llc
0.19
HRT FINANCIAL LLC
0.14
Fundamentals
Market Cap
2.24 mln
PB Ratio
0.32
PE Ratio
0
Enterprise Value
-3.21 mln
Total Assets
4.87 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers Symphony platform, a technology platform comprising Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. It also provides ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the company develops Symphony IL-6 test for the monitoring of disease progression in critical care settings. Further, it develops cardiac biomarkers, such as hsTNT and NT pro-BNP, as well as other tests using the Symphony platform. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.
Organisation
Bluejay Diagnostics Inc
Employees
10
Industry
Medical Devices
CEO
Mr. Indranil  Dey
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step